Gozde Yazici

Gozde Yazici

Auto-generated profile, based on publicly available information

Gozde Yazici

Hacettepe University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2013 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
GYGozde Yazici
Gozde Yazici
TSTolga Yusuf Sanlı
Tolga Yusuf Sanlı
MCMustafa Cengiz
Mustafa Cengiz
DYDeniz Yuce
Deniz Yuce
MGMelis Gultekin
Melis Gultekin
GOGokhan Ozyigit
Gokhan Ozyigit
Background: This study aimed to compare the therapeutic outcomes and fatal carotid blow out syndrome (CBOS) incidence rates between two different stereotactic body radiotherapy (SBRT) protocols. Methods: The study included 75 patients with inoperable locally recurrent head and neck cancer treated with SBRT in our department between June 2007 and March 2011. The first 43 patients were treated sequentially (group I). Then our SBRT protocol was changed due to the high rate of CBOS, and the following 32 patients were treated every other day in a prospective institutional protocol (group II). Results: Median overall survival in group I and group II was 11 months and 23 months, respectively (P = 0.006). We observed 11 cases of CBOS. Only 1 of 7 patients (14%) with CBOS survived in group I, whereas 2 of 4 patients (50%) in group II remain alive. CBOS free median overall survivals were 9 months, and 23 months in group I and group II respectively (P = 0.002). The median radiation dose received by the carotid artery in patients with CBOS was 36.5 Gy (range: 34–42.8 Gy), versus 34.7 Gy (range: 0–44 Gy) in the patients that didn’t have CBOS (P = 0.15). CBOS did not occur in any of the patients with a maximum carotid artery radiation dose <34 Gy. Conclusions: Every other day SBRT protocol for re-irradiation of recurrent head and neck cancer is promising in terms of decreasing the incidence of fatal CBOS.

9 January 2019 in Cureus
Verified
Journal Article
Open access
PDF file
MYMelek Tugce Yilmaz
Melek Tugce Yilmaz
AEAysenur Elmali
Aysenur Elmali
GYGozde Yazici
Gozde Yazici
The abscopal effect is mediated by a systemic anti-tumor immune response and reflects the regression of non-irradiated metastatic lesions at a distance from the primary site of irradiation. This review will focus on understanding the biological rationale behind the abscopal effect of radiotherapy (RT), which has a recently renewed interest as a result of the successes achieved with immunotherapy and RT in combination. Both RT and immunotherapy are standard components of modern treatment regimens. Combination of these two modalities results in an increased response in the irradiated lesions themselves and the metastatic regions distant from the site of irradiation. We will summarize the abscopal effect of radiotherapy, in particular, the synergistic effect of RT and immunotherapy.

25 May 2016 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
GYGozde Yazici
Gozde Yazici
SSSezin Yuce Sari
Sezin Yuce Sari
FYFazli Yagiz Yedekci
Fazli Yagiz Yedekci
AYAltug Yucekul
Altug Yucekul
SBSumerya Duru Birgi
Sumerya Duru Birgi
MCMustafa Cengiz
Mustafa Cengiz
The effects of spinal implants on dose distribution have been studied for conformal treatment plans. However, the dosimetric impact of spinal implants in stereotactic body radiotherapy (SBRT) treatments has not been studied in spatial orientation. In this study we evaluated the effect of spinal implants placed in sawbone vertebra models implanted as in vivo instrumentations. Four different spinal implant reconstruction techniques were performed using the standard sawbone lumbar vertebrae model; 1. L2-L4 posterior instrumentation without anterior column reconstruction (PI); 2. L2-L4 anterior instrumentation, L3 corpectomy, and anterior column reconstruction with a titanium cage (AIAC); 3. L2-L4 posterior instrumentation, L3 corpectomy, and anterior column reconstruction with a titanium cage (PIAC); 4. L2-L4 anterior instrumentation, L3 corpectomy, and anterior column reconstruction with chest tubes filled with bone cement (AIABc). The target was defined as the spinous process and lamina of the lumbar (L) 3 vertebra. A thermoluminescent dosimeter (TLD, LiF:Mg,Ti) was located on the measurement point anterior to the spinal cord. The prescription dose was 8 Gy and the treatment was administered in a single fraction using a CyberKnife® (Accuray Inc., Sunnyvale, CA, USA). We performed two different treatment plans. In Plan A beam interaction with the rod was not limited. In plan B the rod was considered a structure of avoidance, and interaction between the rod and beam was prevented. TLD measurements were compared with the point dose calculated by the treatment planning system (TPS). In plan A, the difference between TLD measurement and the dose calculated by the TPS was 1.7 %, 2.8 %, and 2.7 % for the sawbone with no implant, PI, and PIAC models, respectively. For the AIAC model the TLD dose was 13.8 % higher than the TPS dose; the difference was 18.6 % for the AIABc model. In plan B for the AIAC and AIABc models, TLD measurement was 2.5 % and 0.9 % higher than the dose calculated by the TPS, respectively. Spinal implants may be present in the treatment field in patients scheduled to undergo SBRT. For the types of implants studied herein anterior rod instrumentation resulted in an increase in the spinal cord dose, whereas use of a titanium cage had a minimal effect on dose distribution. While planning SBRT in patients with spinal reconstructions, avoidance of the rod and preventing interaction between the rod and beam might be the optimal solution for preventing unexpectedly high spinal cord doses.

1 January 2023 in Biomarkers in Medicine
Verified
Journal Article
Closed access
Enes ErulEnes Erul
Enes Erul
DGDeniz Can Guven
Deniz Can Guven
YOYakup Ozbay
Yakup Ozbay
AAAhmet Y Altunbulak
Ahmet Y Altunbulak
AKAlper Kahvecioglu
Alper Kahvecioglu
SASercan Aksoy
Sercan Aksoy
Background: We aimed to evaluate the effect of sarcopenia on survival in head and neck squamous cell carcinoma patients treated with chemoradiotherapy. Materials & methods: Disease-free survival an... Plain language summary Head and neck cancer is one of the main causes of cancer-related death worldwide. Most patients are diagnosed in the advanced stage. Muscle wasting with significant weight lo... Tweetable abstract Sarcopenia may be a potential prognostic biomarker for head and neck squamous cell carcinoma patients. Sarcopenic patients have significantly worse survival rates and are more su...

13 June 2024 in Current Treatment Options in Oncology
Verified
Journal Article
Open access
PDF file
MYMelek Tugce Yilmaz
Melek Tugce Yilmaz
SSSezin Yuce Sari
Sezin Yuce Sari
FZFaruk Zorlu
Faruk Zorlu
GYGozde Yazici
Gozde Yazici
Opinion statement: Uveal melanoma is the most common primary ocular tumor in adults. With the evidence demonstrating that episcleral plaque brachytherapy (EPB) has similar survival rates as enucleation in the Collaborative Ocular Melanoma Study (COMS), eye-sparing treatments have come to the fore today. External radiotherapy techniques (proton beam radiotherapy and stereotactic radiosurgery/fractionated stereotactic radiosurgery) are an important treatment option for globe-sparing treatments. There are no prospective randomized trials comparing these techniques; however, retrospective series, meta-analyses, and reviews indicate that these EPB and external radiotherapy techniques are equal. With this review, we aimed to examine the external radiotherapy techniques used in the treatment of uveal melanoma in detail with reference to the current literature.

1 January 2022 in Oral Oncology
Verified
Journal Article
Closed access
SSSezin Yuce Sari
Sezin Yuce Sari
MYMelek Tugce Yilmaz
Melek Tugce Yilmaz
BABurak Yasin Aktas
Burak Yasin Aktas
SASercan Aksoy
Sercan Aksoy
IGIbrahim Gullu
Ibrahim Gullu
GYGozde Yazici
Gozde Yazici